LCID
Lucid Group, Inc.
LCID offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
MYE
Myers Industries, Inc.
MYE has a slight edge over LCID overall, supported by lower modeled downside and stronger modeled upside.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
MYE Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Healthy | |
| Healthy | |
| Stable |
MYE's profitability and cash flow are currently healthy, and its balance sheet is stable, but its revenue is under pressure.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
MYE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 13x | $10.18 | -64% |
| Forward | 14x | $28.32 | — |
| Fair | 20x | $15.32 | -46% |
| Expensive | 31x | $23.28 | -18% |
| Current | 37x | $28.32 | — |
Historical ranges are pointers, not guarantees.
MYE's PE is in its expensive range at 37x. If earnings grow as analysts expect, today's price would be 14x next year's earnings, in its cheap range.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
MYE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect MYE's earnings to grow and its profitability to improve, with its revenue holding steady.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
MYE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.00 | +163% |
| Q3 2026 | $0.76 | +2.7% |
| Q2 2026 | $0.97 | +273% |
| Q1 2026 | $0.70 | +150% |
| Q4 2025 | $0.93 | +389% |
| Q3 2025 | $0.74 | +76% |
| Q2 2025 | $0.26 | -75% |
| Q1 2025 | $0.28 | -74% |
| Q4 2024 | $0.19 | -86% |
MYE has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over MYE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
MYE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $171.3M | -17% |
| Q2 2026 | $179.2M | -14% |
| Q1 2026 | $164.6M | -20% |
| Q4 2025 | $204M | 0% |
| Q3 2025 | $205.4M | +0.2% |
| Q2 2025 | $209.6M | -4.8% |
| Q1 2025 | $206.8M | -0.2% |
| Q4 2024 | $203.9M | +6.7% |
MYE's revenue has slid since its 2022 peak: $171M last quarter, down 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.7% | +0.1 points |
| Q2 2026 | 17% | +7.9 points |
| Q1 2026 | 15% | +7 points |
| Q4 2025 | 9.9% | +2.7 points |
| Q3 2025 | 8.6% | +11 points |
| Q2 2025 | 9.5% | -1.2 points |
| Q1 2025 | 8.1% | +2.8 points |
| Q4 2024 | 7.2% | -2.6 points |
MYE has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
MYE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $11.1M | -48% |
| Q2 2026 | $27.9M | +13% |
| Q1 2026 | $23.4M | +1044% |
| Q4 2025 | $18.9M | -6.3% |
| Q3 2025 | $21.5M | +112% |
| Q2 2025 | $24.7M | +149% |
| Q1 2025 | $2M | -86% |
| Q4 2024 | $20.2M | +71% |
MYE has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
MYE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +136K shares |
| 1 year | +0.9% | +345K shares |
| 3 years | +2.6% | +947K shares |
| 5 years | +4.2% | +1.5M shares |
| Available history | +6.4% | +2.3M shares |
MYE has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $504,000 |
| Q3 2025 | $506,000 |
| Q2 2025 | $507,000 |
| Q1 2025 | $1M |
MYE has spent almost nothing on buybacks in the past year.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MYE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.3x | Moderate |
| Q2 2026 | 2.4x | Moderate |
| Q1 2026 | 2.9x | Moderate |
| Q4 2025 | 3.3x | Elevated |
| Q3 2025 | 3.4x | Elevated |
| Q2 2025 | 4.4x | High |
| Q1 2025 | 4.1x | High |
| Q4 2024 | 4.1x | High |
MYE's net debt is about 2.3 years of its operating earnings (EBITDA), down from 3.4 years a year ago.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
MYE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.8 | Neutral |
| Stochastic | 14.9 | Oversold |
MYE's weekly RSI is 48 (neutral) and its Stochastic is 15 (oversold).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
MYE PE vs Consumer Cyclical Sector
| Metric | MYE | Sector median | Relative |
|---|---|---|---|
| PE | 37x | 18x | 107% above |
| PE % | 88 | 47 | 41 pts above |
MYE is trading at 37x earnings, a 107% premium to the Consumer Cyclical sector's median of 18x.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
MYE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $30.2 | 6.3% below |
| 20 week MA | $31.4 | 9.7% below |
| 50 week MA | $25.7 | 10% above |
| 100 week MA | $19.8 | 43% above |
| 200 week MA | $18.9 | 50% above |
MYE has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
MYE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.5 | $20.3 | +23% |
| 2021 | $20.3 | $19.7 | -2.8% |
| 2022 | $19.7 | $23.1 | +17% |
| 2023 | $23.1 | $19.6 | -15% |
| 2024 | $19.6 | $11.1 | -43% |
| 2025 | $11.1 | $19.3 | +74% |
| 2026 YTD | $19.3 | $28.3 | +47% |
MYE has the edge over LCID on returns for 2026, with the stronger performance.